Stock Analiz

Akso Health Group (AHG) financials: revenue, earnings and cash flow

Fiscal 2017–2026 · from SEC filings · data as of November 13, 2026

Summary

Akso Health’s revenue went from $23M in fiscal 2017 to $14M in fiscal 2026, a decline of about 5.5% a year.

Net income in fiscal 2026 was -$19M, a net margin of -135.0%; the best year in this period was 2018 with $65M.

Free cash flow was -$13M in fiscal 2026 and positive in 3 of the 10 years shown.

Revenue, profit and cash flow by year

Revenue
2017: $23M172018: $107M182019: $4M192020: $7M202021: $2M212022: $6M222023: $13M232024: $2M242025: $15M252026: $14M26$14M
Net income
2017: $9M172018: $65M182019: $6M192020: -$71M202021: -$35M212022: -$17M222023: -$1M232024: -$9M242025: -$135M252026: -$19M26-$19M
Free cash flow
2017: $8M20172018: $87M20182019: -$2M20192020: -$58M20202022: -$9M20222025: $1M20252026: -$13M2026-$13M
EPS (diluted)
2017: $0.01172018: $0.08182019: $0.01192020: $-0.08202021: $-0.04212022: $-0.02222023: $-0.00232024: $-0.01242025: $-0.16252026: $-0.0226$-0.02

Income statement

Fiscal year2026202520242023202220212020201920182017
Revenue$14M$15M$2M$13M$6M$2M$7M$4M$107M$23M
Gross profit-$11315-$281526$122132$1M$605134$2M$7M-$4M$107M$23M
Operating income-$21M-$166M-$9M-$14M-$3M-$4M-$48M-$7M$76M$10M
Net income-$19M-$135M-$9M-$1M-$17M-$35M-$71M$6M$65M$9M
EPS (diluted)$-0.02$-0.16$-0.01$-0.00$-0.02$-0.04$-0.08$0.01$0.08$0.01
R&D————$421186$441405$117942$0$3M$2M
Revenue growth−6.4%+512.1%−81.7%+108.9%+259.6%−74.6%+87.1%−96.5%+368.0%—

Cash flow

Fiscal year2026202520242023202220212020201920182017
Operating cash flow-$13M$1M$1M-$3M-$9M$10M-$58M-$2M$88M$8M
Capital spending-$1638-$154460——-$4861—-$200360-$7590-$456030-$287765
Free cash flow-$13M$1M——-$9M—-$58M-$2M$87M$8M
Dividends paid———————$20M$0$0
Buybacks——————$3M$1M——
Stock-based pay————$391625$55468$347466$7M$2M$0

Balance sheet

Fiscal year2026202520242023202220212020201920182017
Cash$170572$176M$85M$8M$18M$15M$7M$57M$133M$19M
Debt$25132$81737———$10M$21M$20M——
Equity$181M$199M$138M$9M$12M$17M$48M$127M$140M$24M
Total assets$190M$215M$142M$20M$63M$32M$80M$173M$164M$28M
Shares (diluted)857M857M857M857M857M857M857M857M857M857M

Margins and returns

Fiscal year2026202520242023202220212020201920182017
Gross margin-0.1%-1.9%5.1%9.6%9.6%100.0%100.0%-100.2%100.0%100.0%
Operating margin-149.7%-1125.4%-357.8%-108.2%-51.7%-241.7%-695.7%-194.6%70.7%43.2%
Net margin-135.0%-913.4%-391.8%-10.3%-267.0%-1984.5%-1029.7%149.7%61.1%37.4%
FCF margin-92.5%6.9%——-136.8%—-845.8%-47.0%81.4%34.5%
ROIC-10.3%-68.0%-4.9%-129.2%-21.0%-12.3%-55.2%-3.9%46.4%35.8%
ROE-10.3%-67.8%-6.8%-15.6%-137.2%-201.6%-148.0%4.4%46.8%36.5%

Frequently asked questions

What is Akso Health’s annual revenue?

$14M in fiscal 2026.

How much profit does Akso Health make?

Net income was -$19M in fiscal 2026 (net margin -135.0%).

Is Akso Health’s revenue growing?

No: revenue fell 6.4% in fiscal 2026 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.